Background: The purpose of this study was to determine fragile histidine triad (FHIT) and
INTRODUCTION
Fragile histidine triad (FHIT) is a tumor-suppressor gene isolated and identified by collaborating researchers in the USA and Japan in 1996 and it was shown to span the most common human fragile chromosomal site FRA 3B at 3p14.2. 1, 2 Besides 3p14.2, there are 3 other major regions at 3p shown to be involved in allelic losses in human malignancies: 3p25, 3p21.3 and 3p12. 3, 4 The region 3p14.2 contains FRA3B, 1, 5 familial kidney cancer-associated translocation breakpoint t(3;8)(p14.2;q24), 6 and papilloma virus integration sites. 7 Studies on FHIT gene demonstrated that its expression is altered in many human epithelial cancer cell lines including lung, bladder, breast, cervical carcinomas, and that it is frequently a target of homozygous deletions at 3p14.2. 2, 8, 9 Role of the FHIT gene has been studied in primary cancers of the oral cavity, tongue, oral squamous cell carcinoma and head and neck squamous cell carcinoma. [10] [11] [12] FHIT functions as a tumor suppressor in vivo and in vitro and its over expression induces apoptosis. 10 FHIT gene encodes a 147 amino acid protein showing 69% similarity in a core region of 109 amino acids to diadenosine5',5'''P 1 , P 4 -tetraphosphate (Ap 4 A) hydrolase from the fission yeast Schizosaccaromyces pombe, a member of histidine triad protein family. 1 Aberration of FHIT gene is estimated on the level of DNA loss of heterozigosity analysis (LOH), altered mRNA FHIT transcripts and absence or reduction of the FHIT protein. [13] [14] [15] Fragile histidine triad mRNA alterations are also detected in normal tissues and the abnormality can be due to abnormal splicing and processing of the transcripts, since the gene is located in a region prone to stress-induced damage and some of the genetic changes observed, might be a reflection of an intrinsic instability due to cancer cell growth. 16, 17 The p53 gene is one of the most common tumor-suppressor genes located on the short arm of chromosome 17. It spans a region of 20 kb and is made of 11 exons which encode nuclear phosphoprotein having molecular weight of 53 kDa. 18 The disturbed function of p53 results in uncontrolled proliferation of the cell. The mutations of p53 are present in more than 50% of malignant tumors and are commonly related to early and frequent death, decreased differentiation of cells and early recurrence. [19] [20] [21] In normal tissue p53 protein has a short halflife and cannot be detected using immunohistochemical techniques, whereas the p53 gene mutation produces increased stability and over expression of p53 protein. 22 Keratocystic odontogenic tumor (formerly odontogenic keratocyst) and odontogenic cysts are derived from the remnants of odontogenic epithelial cells. It has been postulated that there is a regulated balance between cell proliferation, differentiation and death in the development of the jaw cysts resulting in the specific histopathology in the lining epithelium. 23 This suggests that different factors may be involved in the development of these lesions, and numerous papers have dealt with the expression of tumor-suppressor genes and oncogens in KOT, DC and RC. [23] [24] [25] [26] [27] [28] [29] [30] [31] The higher incidence of p53 aberration in former OKC then in DC and RC was reported. 23, 24, 27 According to the available literature no studies on FHIT in KOT and odontogenic cysts were performed.
The purpose of this study was to determine differential expression of FHIT as an apoptosis related factor and p53 as a marker for, both cellular proliferation and apoptosis.
Immunohistochemical and molecular methods were used to clarify details of the epithelial lining cells' proliferation and death, particularly with respect to aggressive clinical behavior of former OKCs, in the context of new WHO classification according to which the former OKCs have been classified as benign neoplasm-KOT.
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MATERIALS AND METHODS
Tissue specimens
Ninety two paraffin embedded specimens of odontogenic lesions were obtained from The patients signed informed consent for participating in the research before the surgery.
Immunohistochemical examination of FHIT and p53 proteins
Four μm sections of 92 paraffin embedded samples were cut and mounted on slides for immunohistochemical analysis of FHIT protein (48 male and 44 female, age ranged from 14 to 69, mean age 40.9; 38 KOT, 13 DC, 41 RC). They were further deparaffinized and rehydrated through xylene and graded alcohols, and incubated in 3% H 2 O 2 in methanol for 10 minutes to block endogenous peroxidase activity. Antigen retrieval was then performed by heating slides in microwave oven immersed in citrate buffer (750 W, pH 6, 15 minutes). 
Isolation of DNA and RNA and reverse transcription
After deparaffinisation, 32 genomic DNA from microdissected epithelial cyst lining was extracted from the tissue collected in 500 μl microcentrifuge with digestion buffer (0.9% Tween20, 0.9% Trion X-100, 5 nM EDTA, 2mM DTT, 10 mM TrisHCl, pH 7.5) and Proteinase K (20μg/ml; Roche Diagnostics, Mannheim, Germany). Nucleic acids were quantified by reading UV absorbance at 260 nm. The extracts were stored at -20° until assayed. Control normal DNA of the patients was extracted from corresponding normal tissue surrounding the lesion.
Genomic DNA from micro dissected epithelial lining of frozen samples was extracted as described, but without deparaffinisation. 30 Control normal DNA from the whole blood samples was isolated using a standard phenol-extraction procedure. 33 Total RNA from snap frozen tissue specimens was extracted using RNAzol 
PCR amplification, FHIT and p53 gene expression analysis
The FHIT gene expression analysis was performed by nested RT-PCR method as described previously. 34 Half of microliter of cDNA was used for PCR amplifications with primers 5U2 and 3D2 from FHIT exons 1 and 10, respectively. Two microliters of first PCR products were used for nested PCR amplifications with primers 5U1 and 3D1 from FHIT exons 3 and 10, respectively. The PCR products were resolved by agarose gel electrophoresis (1.5% agarose stained with 0.5 μg/ml ethidium bromide). The sequencing of aberrant PCR products was performed as described previously. 35 The p53 gene expression analysis was performed as described by Li et al. To analyze LOH at the FHIT gene, D3S1300 dinucleotide repeat and D3S4103 trinucleotide repeat were used as described previously 34 .
Loss of heterozigosity analysis (LOH)
LOH at the p53 gene locus was analyzed by VNTR analysis and highly informative exogenic (CA) n repeat as it was previously described. 36 LOH was recognized as visible change in alleles in terms of allele ratio in cyst epithelial lining compared with matching normal tissue.
Statistical analysis
The data of FHIT and p53 protein expression, and LOH analysis for FHIT and p53 gene in KOT, DC and RC, were compared with modified Fisher's exact test as described in SAS Procedures Guide. 37 The proportion of FHIT and p53 aberrant expression was compared to the number of epithelial cell layers using Chi-square test. The SAS System for Windows, Release 8.02, TS Level 02M0 (SAS Institute Inc., Cary, NC, USA) was used.
RESULTS
FHIT and p53 protein expression in paraffin embedded samples
To investigate the reactivity of FHIT protein, we examined 38 KOT, 13 DC and 41 RC samples embedded in paraffin. Reactivity to FHIT was for KOT: (-) 28, (+) 9, (++) 1; for DC: (-) 4, (+) 2, (++) 7; for RC: (-) 20, (+) 12, (++) 9. The intensity of aberrant (negative) immunohistochemical reaction for FHIT protein was different between the three groups (p=0.00078), and it was the highest in KOT, then RC and DC. Although the reaction for FHIT was negative in the majority of specimens, in the cases where the reaction was positive it was observed in the cytoplasm of the epithelial lining (Fig 1) . In KOT, staining was observed mostly in suprabasal cells and in DC and RC in basal to superficial epithelial cells. 
Loss of heterozigosity analysis (LOH)
Thirty one paraffin embedded samples were chosen for LOH analysis of FHIT and p53 loci according to their aberrant immunohistochemical reaction for either FHIT, p53 or both (11 KOT, 10 DC and 10 RC). 75% of the samples were informative for both markers of FHIT locus and 49 % of were informative for p53 locus. Mutation of FHIT other than LOH, was not observed in neither of the specimens, while the mutation at codon 237 of p53 was observed in 2 samples (1 KOT and 1 DC). Normal tissues did not show loss of heterozigosity at the gene loci examined. Loss of heterozygosity of FHIT gene was detected in 22.6% of the samples examined (45% in KOT, 10% in RC, and 10% in DC). Loss of heterozygosity of p53 gene was detected in 12.9% of the samples (27.3% in KOT, 10% in DC and 0% in RC). Protein expression of the two genes was correlated with the results of DNA analysis, and it was noticed that the p53 gene mutation was found in 2 of 11 examined cases of KOT which exhibited normal p53 protein expression. p53 mutation was not found in RC although it would be expected differently based on immunohistochemical analysis which showed strong positive immunohistochemical reaction to p53 in 26% of RC. The results of LOH and other mutation analysis of FHIT and p53 genes in paraffin embedded samples are shown in Table 2 .
FHIT and p53 gene analysis in frozen samples
The frozen samples were analyzed for FHIT and p53 LOH and other mutations. The results of DNA analysis at FHIT and p53 loci in frozen odontogenic cyst samples are shown in Table   3 and Figure 3 and 4. Since there were only six frozen specimens no consistent conclusions can be drawn from the obtained data.
DISCUSSION
Odontogenic tumors and allied lesions have been extensively studied in the past decade and new findings lead to new and improved classification of the lesions. 28, 38 Recent findings concerning the events taking place at the molecular level, together with the clinical behavior of the lesions, gave the better insight into the nature of the lesions. The most recent WHO classification of head and neck tumors referred to the former OKC as keratocystic odontogenic tumor (KOT), a benign odontogenic tumour arising from odontogenic epithelium with mature fibrous stroma without odontogenic ectomesenhyme. 28 Radicular cysts are epithelial lesions which arise from the epithelial residues (rest of Malassez) in the periodontal ligament as a consequence of inflammation which follows the death of a dental pulp. The dentigerous cyst is the second most-frequent cystic lesion of the jaws which usually encloses the crown of un unerrupted tooth.
A new classification gives enlarged terminology and diagnostic framework, but there are still many uncertainties concerning molecular and cellular mechanisms underlying the development and behavior of tumors arising from epithelium of the odontogenic apparatus and allied lesions, which gives the inspiration for further research into the lesions. 23, 26, 39, 40 Altered expression of oncoproteins and tumor-suppressor proteins in odontogenic cysts, and the mutations of genes regulating the cell cycle have been reported for different odontogenic cysts. 23, [25] [26] [27] 29 Furthermore, functional genomic analyses of malignancies related to jaws, support the hypotheses that they can arise from odontogenic cysts, apart from arising de novo or secondary to a tumor. [41] [42] [43] Furthermore, there are reports on transformation of former OKC into squamous cell carcinoma and DC into ameloblastoma. 44, 45 In our study we demonstrated variable expression of FHIT tumor suppressor protein in paraffin embedded samples of odontogenic lesions. Negative immunohistochemical reaction was the highest in KOT (74%) than in RC (49%) and DC (31%). Pavelic 34 reported that FHIT gene is disrupted in head and neck squamous cell carcinomas (HNSCC) and lung cancer, and suggested a strong correlation between the loss of FHIT protein function and increased tumor cell proliferation and low rate of apoptosis. Former OKCs recur at greater frequency and their epithelial lining has greater proliferative potential than that of other types of odontogenic cysts. 26, 27, 29 Our results, showing the highest negative reaction to FHIT in KOT, suggest that the disruption of FHIT may induce cell proliferation.
Loss of heterozygosity of FHIT gene was detected in 45% of informative cases of KOT, 10% of DC, and 10% of RC. In frozen specimens, FHIT gene LOH was observed in three, out of six, specimens (2 RC, 1 KOT). Loss of exons 6-7 of the FHIT gene was found in KOT specimen. Loss of FHIT protein function and higher incidence of FHIT mutation in benign neoplasm KOT, may be important in its development and/or progression.
Given that defective FHIT genes were found in DC and RC, the inactivation of FHIT gene is likely to be an early event in the pathogenesis of odontogenic cysts. Our data suggest strong difference in the FHIT aberration between KOT and DC and RC. Less aggressive DC and RC have much less incidence of FHIT loss in comparison to KOT. It was reported that the FHIT gene could be aberrant in non-neoplastic or premalignant tissues, although the changes increased with progression of lesions from normal tissue and dysplasia to carcinoma in situ and cancer. Therefore, the authors suggested that the presence of abnormal FHIT transcripts is not cancer specific in the case of lung cancer, and the abnormality may be due to abnormal splicing and processing of the transcripts since the gene is located in a region prone to stress-induced damage. 17 Furthermore, some studies reported that some mutagenic compounds such as benzo()piren diol-epoxide, which is a major constituent of tobacco smoke, induce molecular alterations of FHIT and p53 gene in human lung cancer. 34 Both p53 and FHIT tumor suppressor gene mutations have been frequently found in other types of carcinomas. 2, 11, 15, 35, 46 According to the available literature FHIT gene has not been studied in odontogenic cysts and KOT.
The frequency of positive immunohistochemical reaction for p53 protein in paraffin embedded specimens of KOT, DC and RC was 29%, 15% and 26%, respectively, and there was no difference between the three groups (p=0.9344). The intensity of p53 immunostaining was weak, and in KOT it was mostly observed in suprabasal cells, and in DC and RC in basal to superficial epithelial cells which is in concordance with previous reports. 23, 27, 29 Loss of heterozygosity of p53 gene was detected in 27.3% of informative cases of KOT and 10% of DC, while it was not observed in RC. The mutation of p53 gene at codon 237 was observed in 2 paraffin embedded specimens (1 KOT and 1 DC). In snap frozen specimens, p53 mutation at codon 237 was found in KOT.
Our results as well as those of other authors show that p53 mutations are more frequently present in KOT i.e. former OKC, compared with other types of cysts. 21, 23, 27, 29 However, we did not find any mutation in RC. These results support the assumption that the inactivation of p53 may confer odontogenic lesions with local growth and aggressive properties attributed to KOT. Agaram 24 also reported that a significant number of former OKC show clonal LOH of p53, along with LOH of some other common tumor-suppressor genes. Furthermore, the inactivation of p53 could even be one event in the multi-step genetic process leading to the malignant transformation of KOT and DC reported in the literature. 41, 44, 45 Immunohistochemical analysis showed that the samples with more than 5 epithelial cell layers gave positive reaction to p53 in significantly more cases (p<0.05) which confers the lesions with increased cell division and local growth. This is in concordance with Regezi 47 report where the mitotic index in OKC was similar to that in ameloblastoma.
In conclusion, our results support the hypothesis that FHIT gene alteration is involved in development of KOT and odontogenic cysts, and that aberrant FHIT and p53 genes could be markers of local invasiveness or even neoplastic nature. Aberrant FHIT gene may be early event in odontogenic cyst development. 
